Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial (vol 8, pg 582, 2020)

被引：0
|
作者：
Cherney, D. Z. I.
Dekkers, C. C. J.
Barbour, S. J.
机构：
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 08期
关键词：
D O I：
10.1016/S2213-8587(20)30217-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E3 / E3
页数：1
相关论文
共 50 条
  • [1] Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
    Cherney, David Z., I
    Dekkers, Claire C. J.
    Barbour, Sean J.
    Cattran, Daniel
    Gafor, Abdul Halim Abdul
    Greasley, Peter J.
    Laverman, Gozewijn D.
    Lim, Soo Kun
    Di Tanna, Gian Luca
    Reich, Heather N.
    Vervloet, Marc G.
    Wong, Muh Geot
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (07): : 582 - 593
  • [2] Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial
    Sławomir Lizakowski
    Leszek Tylicki
    Marcin Renke
    Przemysław Rutkowski
    Zbigniew Heleniak
    Maja Sławińska-Morawska
    Ewa Aleksandrowicz
    Wieslawa Łysiak-Szydłowska
    Bolesław Rutkowski
    International Urology and Nephrology, 2012, 44 : 1763 - 1770
  • [3] Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial
    Lizakowski, Slawomir
    Tylicki, Leszek
    Renke, Marcin
    Rutkowski, Przemyslaw
    Heleniak, Zbigniew
    Slawinska-Morawska, Maja
    Aleksandrowicz, Ewa
    Lysiak-Szydlowska, Wieslawa
    Rutkowski, Boleslaw
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (06) : 1763 - 1770
  • [4] Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial
    Op den Kamp, Yvo J. M.
    de Ligt, Marlies
    Dautzenberg, Bas
    Kornips, Esther
    Esterline, Russell
    Hesselink, Matthijs K. C.
    Hoeks, Joris
    Schrauwen-Hinderling, Vera B.
    Havekes, Bas
    Oscarsson, Jan
    Phielix, Esther
    Schrauwen, Patrick
    DIABETES CARE, 2021, 44 (06) : 1334 - 1343
  • [5] Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial (vol 44, pg 1334, 2021)
    den Kamp, Yvo J. M. Op
    de Ligt, Marlies
    Dautzenberg, Bas
    Kornips, Esther
    Esterline, Russell
    Hesselink, Matthijs K. C.
    Hoeks, Joris
    Schrauwen-Hinderling, Vera B.
    Havekes, Bas
    Oscarsson, Jan
    Phielix, Esther
    Schrauwen, Patrick
    DIABETES CARE, 2022, 45 (05) : 1297 - 1297
  • [6] SGLT2 inhibitors to prevent diabetic kidney disease (vol 8, pg 4, 2020)
    Fioretto, P.
    Vettor, R.
    Pontremoli, R.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (02): : E1 - E1
  • [7] Comment on "The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease"
    Chen, I. -Wen
    Chang, Li-Chen
    Hung, Kuo-Chuan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (06) : 2115 - 2116
  • [8] Comment on “The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease”
    I.-Wen Chen
    Li-Chen Chang
    Kuo-Chuan Hung
    International Urology and Nephrology, 2024, 56 : 2115 - 2116
  • [9] THE EFFECT OF VARIOUS TYPES OF THE RENIN-ANGIOTENSIN-ALDOSTERON SYSTEM BLOCKADE ON PROTEINURIA IN CHRONIC NON-DIABETIC KIDNEY DISEASE: A DOUBLE-BLIND CROSS-OVER RANDOMISED CONTROLLED TRIAL
    Lizakowski, Slawomir
    Rutkowski, Przemyslaw
    Tylicki, Leszek
    Rutkowski, Przemyslaw
    Renke, Marcin
    Sulikowska, Beata
    Donderski, Rafal
    Bednarski, Rafal
    Heleniak, Zbigniew
    Przybylska, Milena
    Manitius, Jacek
    Rutkowski, Boleslaw
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 109 - 109
  • [10] FINERENONE ADDED TO RAS/SGLT2 BLOCKADE FOR NON-DIABETIC CHRONIC KIDNEY DISEASE: RESULTS OF A PRECLINICAL DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL
    Zhu, Zhihui
    Kusunoki, Yoshihiro
    Rosenkranz, Karoline
    Li, Chenyu
    Klaus, Martin
    Gross, Oliver
    Angelotti, Maria Lucia
    Cirillo, Luigi
    Romagnani, Paola
    Buelow, Roman David
    Boor, Peter
    Anders, Hans-Joachim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I51 - I52
12345